1603OInitial results of phase I study of DCC-2618, a broad-spectrum KIT and PDGFRa inhibitor, in patients (pts) with gastrointestinal stromal tumor (GIST) by number of prior regimens. (23rd October 2018) - George, S; Heinrich, M; Chi, P; Razak, A; von Mehren, M; Gordon, M; Ganjoo, K N; Somaiah, N; Trent, J C; Rodon Ahnert, J; Wolf, J; Ruiz-Soto, R; et al.